Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer (CheckMate649)
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Capecitabine; Capecitabine; Fluorouracil; Fluorouracil; Folinic acid; Folinic acid; Oxaliplatin; Oxaliplatin
- Indications Gastric cancer; Oesophageal cancer
- Focus Registrational; Therapeutic Use
- Acronyms CheckMate649
- Sponsors Bristol-Myers Squibb
- 06 Jun 2017 Trial design of the study presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 17 Apr 2017 Planned End Date changed from 11 Oct 2020 to 1 Oct 2020.
- 17 Apr 2017 Planned primary completion date changed from 11 Jul 2019 to 1 Jul 2019.